State of M&A Data Rooms — Q2 2026 Read the report →

How to Raise Capital in 2026: Equity, Debt, and Hybrid Options Compared

M&A advisory at Peony. Former investment banker at Moelis & Company, where I worked on cross-border M&A across healthcare, industrials, and consumer. I write about how deals actually get diligenced and closed.

How to Raise Capital in 2026: Equity, Debt, and Hybrid Options Compared

Last updated: August 2026

Quick answer. There are three families of capital: equity (selling ownership — no repayment, but dilution), debt (borrowing — full ownership, but it must be serviced from cash flow), and hybrid instruments that sit between them (convertible notes, SAFEs, mezzanine, preferred). You pick by three things: your stage, how much dilution you can tolerate, and your cash-flow profile. The process itself is the same shape every time — prepare the story and numbers, build a target list, run outreach, survive diligence, and negotiate a term sheet to close.

I'm Chris Chen. Before joining Peony, I worked in M&A at Moelis & Company across cross-border, healthcare, industrials, and consumer transactions. Capital raising sat next to every mandate I touched — a sale process would pause for a recap, a carve-out would need debt lined up, a founder would ask whether to raise equity or lever the business instead. What I saw over and over is that founders and CFOs usually see only one lane: the last raise they did, or the loan their bank offered. The actual menu is much wider, and the right instrument is often not the one they already know. This post is the full menu, laid out with honest trade-offs rather than a pitch for any single path.

It is deliberately the umbrella, not the deep dive. Where a topic has its own detailed guide on this site — the stage-by-stage startup ladder, the mechanics of a SAFE, how dilution math works — I point you there instead of repeating it. The job here is to help you see all the options at once and choose the right lane before you go deep on any one of them.

How do companies raise capital?

Companies raise capital by selling ownership (equity), borrowing money (debt), or using an instrument that blends the two (hybrid). That is the whole map, and almost every funding method you have heard of is a variant inside one of those three families. The reason the distinction matters is that each family has a fundamentally different consequence: equity costs you ownership but never has to be repaid, debt preserves ownership but must be serviced from cash flow, and hybrids trade a bit of each. Get the family right first, then pick the specific instrument.

Here is the master view — the three families and their representative instruments, scored on the four dimensions that actually drive the decision.

InstrumentWho it fitsDilutionCostSpeed
Angel / venture equityPre-revenue to high-growth startupsHighHighest cost of capitalWeeks to months
Growth equityProven companies scaling, minority stakeModerateHighMonths
Private equity (buyout)Mature, cash-generative companiesHigh (majority)HighMonths
Equity crowdfundingConsumer / community brands, early companiesModerateModerate + platform feesWeeks to months
Bank term loan / lineProfitable businesses with collateral or cash flowNoneLow (interest, tax-deductible)Weeks to months
SBA 7(a) loanSmall businesses that fit SBA criteriaNoneLowWeeks to months
Venture debtVenture-backed startups extending runwayLow (warrants)ModerateWeeks to months
Private credit / direct loanMid-market companies too large for a bank lineNoneModerate to highWeeks to months
Revenue-based financingRecurring-revenue businesses without collateralNoneModerate to high (cap multiple)Days to weeks
Convertible note / SAFEEarly-stage bridges before a priced roundDeferredLow to paperDays to weeks
Mezzanine / preferredEstablished companies filling a capital-stack gapLow to moderateHigh (between debt and equity)Months
Bonds / public offeringLarge issuers with scale and reporting maturityVariesVariesMonths

The four columns are the questions worth internalizing. Dilution is how much ownership you surrender. Cost is the true cost of the capital — and note that equity, which feels "free" because nothing is repaid, is usually the most expensive form, because equity investors demand a higher return than lenders for bearing last-loss risk. Speed is how fast the money can realistically arrive. And who it fits is mostly a function of stage and cash flow. The rest of this guide walks each family, then gives you a framework for choosing.

How do you raise equity capital?

You raise equity capital by selling newly issued ownership to investors, and the specific route depends almost entirely on your stage and size. Equity shares your downside — if the company struggles, investors lose alongside you rather than foreclosing — which is exactly why companies that cannot yet service debt lean on it. The instruments and the dilution math behind them are covered in depth in what is equity financing; here is the routing map of who raises equity and how.

  • Angel and venture rounds. The startup path: angels and venture funds buy equity (or equity-like SAFEs and notes) keyed to milestones, from pre-seed through the later series. The full stage-by-stage narrative — check sizes, valuations, dilution, and timelines at each round — lives in the startup fundraising rounds guide, and how to actually run that process is in the startup fundraising strategy guide. I will not repeat those here.
  • Growth equity. Once a company has real revenue and a proven model, growth-equity investors take a minority stake to fund expansion — new markets, acquisitions, a sales build-out — usually without a change of control. It is less dilutive per dollar than early-stage equity because the valuation is higher.
  • Private equity. For mature, cash-generative companies, private-equity firms buy a minority or majority position. A majority buyout is a control transaction, often financed partly with debt, and typically involves a change in governance. This is the exit or partial-liquidity path for many established private companies.
  • Strategic investors. A larger company in your industry invests for strategic reasons — access to your technology, a commercial partnership, an eventual acquisition. Strategic capital can come with commercial upside but also with strings, so the terms deserve close reading.
  • Equity crowdfunding. Under U.S. rules, a company can raise from the general public online. Regulation Crowdfunding permits up to $5 million in a 12-month period through an SEC-registered portal. Regulation A goes further: Tier 1 allows up to $20 million and Tier 2 up to $75 million in a 12-month period, per the SEC. Most traditional private raises instead use Regulation D Rule 506, which has no dollar cap but limits the raise to accredited investors (plus up to 35 non-accredited purchasers under 506(b)). This is general information, not legal advice — which exemption fits is a question for securities counsel.

The common thread across every equity route is that capital comes in and ownership goes out, permanently. That is the price of capital that never has to be repaid.

How do you raise debt capital?

You raise debt capital by borrowing a sum you agree to repay with interest, keeping full ownership of the company. Debt is usually the cheaper cost of capital — a lender accepts a capped, contractual return and sits ahead of equity if things go wrong — and the interest is generally tax-deductible. The catch is that it must be serviced from cash flow regardless of how the business is doing, it adds default risk, and it typically comes with covenants. This is the family the startup-heavy corner of the internet under-explains, so it is worth walking properly.

  • Bank term loans and lines of credit. The workhorse for profitable businesses. A term loan is a fixed sum repaid over years; a revolving line of credit is a flexible balance you draw and repay as working capital demands. Both usually require collateral, a track record, or reliable cash flow, which is why they are hard for a pre-revenue company to obtain.
  • SBA loans. The U.S. Small Business Administration guarantees loans made by lenders, which lowers the risk to the bank and widens access for small businesses. The flagship 7(a) program is capped at $5 million per loan. As of July 4, 2026, the SBA raised the combined cap so a borrower can access up to $10 million across a 7(a) and a 504 loan together, per the SBA — the highest level in the agency's history.
  • Venture debt. A loan sized against a startup's recent equity raise and investor backing, used to extend runway between rounds without much dilution (lenders usually take warrants). It is a real and growing market: U.S. venture debt hit a record $68.8 billion in 2025, according to the Runway Growth Capital and PitchBook Venture Debt Review released in May 2026. It sits alongside the equity rounds it complements, not in place of them.
  • Private credit and direct lending. Non-bank funds lend directly to companies — typically mid-market businesses that are too large for a simple bank line but not issuing public bonds. This has become one of the largest pools of capital in the market: Morgan Stanley estimates the private credit market in the $2 to $3 trillion range as of 2025 and projects it toward $5 trillion by 2029. Pricing is higher than a bank loan but the capital is flexible and fast.
  • Revenue-based financing. An advance you repay as a fixed percentage of monthly revenue until you have paid back a predetermined cap multiple of the original amount — commonly in the range of 1.3x to 3x. Payments rise and fall with your sales, which suits recurring-revenue businesses that lack hard collateral. There is no dilution, but the effective cost can be high.
  • Bonds. For large companies with scale and reporting maturity, issuing bonds raises debt from many investors at once. This is out of reach for most private companies and is listed to complete the map.

The through-line: debt keeps your equity intact but demands that the business can pay it back on a schedule. That is why it fits predictable, cash-generative companies and struggles to fit anything pre-revenue.

What are hybrid instruments?

Hybrid instruments blend debt and equity features, which places them between the two families on the risk and cost spectrum. Companies reach for them when straight debt is unavailable and a full priced equity round is either premature or too dilutive — the hybrid fills the gap. There are four you will encounter.

  • Convertible notes are genuinely debt — they accrue interest and have a maturity date — but they are written to convert into equity at your next priced round, usually with a discount or a valuation cap that rewards the early investor. They are the classic early-stage bridge.
  • SAFEs (Simple Agreements for Future Equity) do the same job without being debt at all: no interest, no maturity, just the right to shares at the next priced round. The full mechanics — post-money versus pre-money, caps and discounts — are in what is equity financing, so I will not re-teach them here.
  • Mezzanine financing is subordinated debt that sits below senior loans in the capital stack and often carries warrants for upside. Because it is closer to equity in repayment priority, it is priced higher than senior debt. Established companies use it to fill a financing gap in a buyout or expansion.
  • Preferred stock is equity with debt-like protections — a liquidation preference that pays holders before common shareholders on an exit, and sometimes a dividend. It is the standard instrument in priced venture and growth rounds.

The way to hold all four in your head is by where they land: a SAFE and a convertible note are early-stage bridges near the equity end; mezzanine and preferred are later-stage structures that established companies use to tune the balance between dilution and repayment risk.

How do you choose between equity and debt?

Choose based on whether your company can reliably service debt from cash flow: if it can, debt is usually cheaper and preserves ownership; if it cannot, equity is often the only realistic option. That single test resolves most cases, but five factors sharpen the decision.

  • Stage. A pre-revenue company has no cash flow to service a loan, so debt is either unavailable or ruinously restrictive — equity is the capital that can wait for growth. A mature, profitable company can borrow cheaply and often should, to avoid selling more of itself.
  • Predictability of cash flows. Debt rewards predictability. If revenue is recurring and steady, a lender can underwrite it and you keep your equity. If revenue is lumpy or unproven, debt covenants become a trap and equity's downside-sharing is worth the dilution.
  • Dilution math. Run the actual numbers. Equity is permanent — every point you give up is a point of all future upside. If the capital will make the company enough more valuable that a smaller slice is worth more in dollars, dilution is fine; if not, borrow instead. The mechanics of that calculation are worked through in what is equity financing.
  • Covenants and control. Debt comes with covenants that constrain what you can do but leaves your cap table alone. Equity leaves you operationally freer in the short term but adds shareholders who may hold board seats, veto rights, and a permanent claim. You are trading one kind of control for another.
  • Cost of capital. Debt is usually cheaper; equity is usually the most expensive form of capital precisely because it feels free. Weigh the tax-deductible interest of a loan against the open-ended cost of selling upside.

In practice, many companies use both over their lifetime, and often in that order — equity to fund the risky, unprofitable early years, then debt once cash flows are stable enough to service it. The two are not rivals so much as tools for different stages of the same company.

How does a capital raise actually run?

Whatever instrument you choose, a raise runs through the same five stages, and the difference between a clean process and a painful one is almost entirely preparation. I ran versions of this sequence on every mandate at Moelis, and the shape holds whether you are raising a seed round or a mid-market debt facility.

  1. Prepare the story and the numbers. Before you talk to anyone, assemble the narrative and the evidence: what the company does, why now, the financial model, the historical financials, and the metrics that prove the thesis. This is also where you build the disclosure set you will share.
  2. Build the target list. Identify the investors or lenders whose mandate actually fits your stage, sector, and instrument. A tight list of the right counterparties beats a broad blast to the wrong ones every time.
  3. Run outreach. Reach the list through warm introductions where you can and direct outreach where you cannot, sharing a teaser or deck and moving interested parties into real conversations.
  4. Survive diligence. Interested investors and lenders dig in — financials, contracts, cap table, KPIs. This is where raises slow down, and almost always because documents are scattered rather than because the answer is no.
  5. Negotiate the term sheet to close. Agree on price and terms, paper the deal with counsel, and move to signing and funding.

Stages one and four are where the data room earns its place. A raise rarely stalls on the term sheet; it stalls while a founder scrambles to assemble documents an organized room would have had ready — and a disorganized shared drive quietly signals to a sophisticated investor that operations are loose. I run Peony, a data room company, and the pattern I see across 6,800+ customers is consistent: the raises that close fastest are the ones where the room was built before the first meeting, not during diligence. For exactly what to stage and how, the data room for investors guide is the practical companion to this section.

How long does a raise take and what does it cost?

A raise takes anywhere from a few weeks to several months depending on the instrument, and it costs a mix of advisory fees, legal fees, and internal time — but the only honest numbers are sourced ones, so here is what the data actually says and where the ranges are too deal-specific to quote.

On timeline, the instrument sets the pace. A small SAFE or convertible note can close in weeks once investors are committed. A priced venture round typically runs a few months from first outreach to funding. A bank or private-credit facility usually takes one to three months through underwriting and documentation. Growth-equity and private-equity processes often run three to six months because diligence is deeper and the check is larger. These are ranges, not promises — the variable you control most is how ready your materials are.

On cost, three buckets matter:

  • Advisory or placement fees. When a placement agent or banker runs a private capital raise, success fees commonly run about 1.5% to 2.5% of the capital raised, and 2% to 2.5% on smaller funds, according to Pipeline Road's 2026 placement-fee analysis; retainers frequently run $25,000 to $100,000. For company sales and larger capital raises, advisory fees scale inversely with deal size — beginning near 10% on the first tranche of a sub-$10M deal and stepping down to roughly 1% to 2% on deals above $100M, per Axial's 2026 M&A Fee Guide. Many small companies raise without an agent at all, in which case this bucket is zero.
  • Legal fees. These vary widely by instrument and complexity, so I will not invent a number. Directionally: a SAFE or note is cheap to paper, a priced equity round or a negotiated debt facility costs meaningfully more because the documents and negotiation are heavier. Get a fixed-fee or capped quote from counsel before you start.
  • Internal time. The least visible and often the largest cost — the weeks of founder and CFO attention a raise consumes. Preparation reduces it, which is the entire argument for having your disclosure organized before you begin.

The responsible way to read all of this: name the source for every number, and treat anything unsourced as a range that depends on your specific deal.

What do investors and lenders diligence?

Investors and lenders diligence the same core set regardless of instrument: your financials, your cap table, your material contracts, and the KPIs behind your story — because they are all trying to answer one question, which is whether the numbers and the risks are what you say they are. An equity investor weighs the upside and the ownership they are buying; a lender weighs your ability to repay and the collateral behind it. The documents they ask for overlap heavily.

Expect requests for financial statements and a model, the capitalization table and any prior notes or SAFEs, incorporation and governance documents, key customer and supplier contracts, IP assignments, employment agreements, and the operational metrics that support your projections. A debt process adds a sharper focus on cash flow, existing obligations, and covenants; an equity process digs harder into growth and market. Either way, the due diligence preparation guide is the checklist-level companion to this section, and if you are raising as an independent sponsor or search-fund operator, the independent sponsor capital raising guide covers that specific process end to end.

The practical takeaway is the one I opened with: the raise moves at the speed you can produce these documents. That is a preparation problem, not a fundraising problem — and it is the most fixable part of the entire process. For how founders run that disclosure on our platform, /solutions/fundraising walks through it.

Frequently asked questions

How do companies raise capital?

Companies raise capital in three families. Equity means selling ownership — angel and venture rounds, growth equity, private equity, strategic investors, or equity crowdfunding — with no repayment but permanent dilution. Debt means borrowing and repaying with interest, keeping full ownership: bank term loans and lines, SBA loans, venture debt, private credit, revenue-based financing, or bonds. Hybrid instruments sit between the two — convertible notes, SAFEs, mezzanine, and preferred stock. Which family fits depends on your stage, how predictable your cash flows are, how much dilution you can tolerate, and how much control you want to keep. Most companies use more than one over their life.

What are the ways to raise capital for a business?

The practical menu, from least to most dilutive: reinvested profit and founder capital; grants and non-dilutive programs; bank term loans and lines of credit; SBA-backed loans; revenue-based financing; venture debt; private credit or direct lending; convertible notes and SAFEs; preferred equity and mezzanine; priced equity rounds from angels, venture, growth, or private-equity investors; equity crowdfunding under Regulation Crowdfunding or Regulation A; and, for large issuers, public bonds or a public offering. A cash-generative business leans toward debt; a pre-revenue or fast-scaling one usually needs equity. Stage and cash-flow profile decide the shortlist more than preference does.

What is the difference between equity and debt financing?

Debt is borrowed money you repay with interest on a schedule; you give up no ownership, the interest is generally tax-deductible, and it is usually the cheaper cost of capital — but it must be serviced from cash flow, adds default risk, and comes with covenants. Equity is capital raised by selling shares; there is no repayment and investors share the downside, but you permanently dilute ownership and control, and it is typically the more expensive form because investors demand a higher return for last-loss risk. Profitable, predictable businesses favor debt; early-stage and high-growth companies default to equity because they cannot reliably service a loan.

How much does it cost to raise capital?

Costs fall into advisory fees, legal fees, and internal time. When a placement agent or banker runs a private raise, success fees commonly run about 1.5% to 2.5% of capital raised, and 2% to 2.5% on smaller funds, per Pipeline Road's 2026 placement-fee data; retainers often run $25,000 to $100,000. For company sales and larger capital raises, advisory fees scale by deal size — beginning near 10% on the first tranche of a sub-$10M deal and stepping down to roughly 1% to 2% on deals above $100M, per Axial's 2026 M&A Fee Guide. Legal fees vary widely by instrument and complexity; a priced round costs far more to paper than a SAFE.

How long does a capital raise take?

It depends on the instrument and your readiness, not the calendar. A small SAFE or convertible note can close in weeks once you have committed investors. A priced venture round typically runs a few months from first outreach to wired funds. A debt facility from a bank or private-credit lender usually takes one to three months through underwriting and documentation. Growth-equity and private-equity processes often run three to six months because diligence is deeper. The single biggest variable you control is preparation: raises rarely stall on the term sheet, they stall while someone assembles documents an organized data room would have had ready.

How do you raise capital without giving up equity?

Use debt or non-dilutive capital. Bank term loans and lines of credit, SBA 7(a) loans (capped at $5 million per loan, with a combined 7(a)-plus-504 limit of up to $10 million as of July 2026 per the SBA), venture debt, and private credit all provide cash you repay without selling shares. Revenue-based financing advances capital you repay as a fixed percentage of monthly revenue until a cap multiple is reached — useful for businesses with recurring revenue and no collateral. Grants, tax credits, and reinvested profit are fully non-dilutive. The trade-off is that debt must be serviced from cash flow and carries covenants, so it fits predictable businesses better than pre-revenue ones.

What is the difference between a capital raise and a loan?

A loan is one specific way to raise capital — it is debt. A capital raise is the broader act of bringing outside money into the business, which can be debt, equity, or a hybrid. So every loan is a capital raise, but not every capital raise is a loan. The distinction people usually mean is equity versus debt: a loan keeps your ownership intact and must be repaid with interest, while an equity raise sells a piece of the company and never has to be paid back. Choosing between them turns on your cash flow, stage, and appetite for dilution rather than a label.

How do you raise capital for a startup versus an established company?

A startup with little revenue cannot service debt, so it raises equity — angel checks, SAFEs, and priced venture rounds keyed to milestones. Our startup fundraising rounds guide maps that ladder stage by stage. An established private company with steady cash flow has the full menu: it can borrow through banks or private credit, take growth equity for expansion without a control change, or sell a majority to a private-equity buyer. The rule of thumb is that equity funds risk and growth before cash flows are reliable, while debt funds predictable businesses more cheaply. Many companies move from equity-heavy to debt-capable as they mature.

What are hybrid financing instruments?

Hybrids blend features of debt and equity so they sit between the two on the risk and cost spectrum. Convertible notes are debt that converts into shares at a later priced round, carrying interest and a discount or valuation cap. SAFEs do the same job without being debt at all. Mezzanine financing is subordinated debt that often includes warrants, priced above senior loans because it sits closer to equity in the capital stack. Preferred stock is equity with debt-like protections such as a liquidation preference and, sometimes, a dividend. Companies reach for hybrids when straight debt is unavailable and a full priced equity round is premature or too dilutive.

How much can you raise through equity crowdfunding?

Under U.S. rules, Regulation Crowdfunding lets a company raise up to $5 million from the general public in a 12-month period through an SEC-registered portal, per the SEC. For larger online raises, Regulation A has two tiers: Tier 1 allows up to $20 million and Tier 2 up to $75 million in a 12-month period. Traditional private raises under Regulation D Rule 506 have no dollar cap but are limited to accredited investors, plus up to 35 non-accredited purchasers under 506(b). This is general information, not legal advice — the exemption you qualify for is a question for securities counsel.

What documents do investors expect in a capital raise, and how should you share them?

Investors and lenders expect the same core set: financial statements and a model, the cap table, incorporation and governance documents, material customer and supplier contracts, and the KPIs behind your story. The raise then moves at the speed you can produce them. Sharing them through an organized data room rather than email attachments signals operational competence and lets you control disclosure — NDA gating before access and page-level analytics that show which investors actually opened the model, so you prioritize the engaged ones. It is why 6,800+ customers run raises on Peony: analytics and link expiry are on every tier including the free plan ($0, 50 documents), Business is $30 and Data Room $52 per admin per month.